ISIS kills and plunders for their prophet. Big Pharma kills and plunders for their profits. The biggest evil in the history of mankind is the American medical industrial complex. We are spending billions of dollars fighting members of ISIS and other Islamic terrorist groups who kill people for their prophet Mohammad while we ignore a the medical industry that is the leading cause of death and the biggest thief in the US. Google it. Well I did.
I military solution will not work to defeat ISIS but military solution could within a day defeat an enemy like big pharma.
- People also ask
UPDATED: Merck's melanoma 'game-changer' Keytruda ...
www.fiercepharma.com/story/mercks-melanoma.../2014-09-05
Sep 5, 2014 - Then came this news: Merck said Keytruda (pembrolizumab) would cost$12,500 per patient per month, or $150,000 per year. Keytruda is the latest in a string of breakthrough cancer therapies that are helping push the overall market for oncology drugs to $100 billion a year.As PD-1 costs emerge, nivo looks to be twice the price
https://www.epvantage.com/Universal/View.aspx?type=Story&id...
Sep 5, 2014 - Analysts assume that in practice pembrolizumab could cost patients$12,500 a month – more than in the above scenarios because of wastage of drug due to the amount remaining in a vial being discarded. Either way, the same argument could be made with nivolumab, so the comparison between the drugs holds.Cost of Immunotherapy Projected to Top $1 Million per ...
www.ascopost.com/.../cost-of-immunotherapy-projected-to-top-$1-milli...
Jul 10, 2015 - He cited the current per-mg costs to be $28.78 for nivolumab and ... Dr. Saltz also questioned the need to use pembrolizumab at a dose of 10 ...KEYTRUDA® (pembrolizumab) | The Merck Co-Pay ...
https://www.merckaccessprogram-keytruda.com/.../the-merck-copay-assi...
Review the eligibility requirements for the Merck Co-Pay Assistance Program to learn if your patient may be eligible for co-pay assistance for KEYTRUDA® ...New Immunotherapy Costing $1 Million a Year - Medscape
www.medscape.com/viewarticle/845707
Jun 1, 2015 - CHICAGO — One of the new immunotherapies would cost more than $1 million per patient per year at the higher dose currently being studied ...
Medscape
(Pembrolizumab)Cost - Houston Chronicle
www.chron.com/...cost.../The-cost-of-cancer-drugs-7...
Price of a year's treatment for 10 cancer drugs. The following ... Drug: Keytruda (
Houston Chronicle
(PBS) listing of Keytruda® (pembrolizumab) - Department of ...
www.health.gov.au/.../MC15-006518-PBS-list-of-k...
Oct 23, 2015 - The PBAC considers each PBS listing submission having regard to the safety, clinical effectiveness and cost-effectiveness (value-for-money) of ...
Department of Health
FDA Approves Merck's New-Wave Cancer Drug - WSJ
www.wsj.com/.../fda-approves-mercks-cancer-dr...
Sep 4, 2014 - New Treatment, Which Costs $150,000 a Year, Is Aimed at ... and Drug Administration cleared the drug, pembrolizumab, for the treatment of a ...
The Wall Street Journal
